Articles tagged with Oligodendrocytes
The NINDS R35 grant will fund the Casaccia lab's work to elucidate signals regulating oligodendrocyte progenitor cells in healthy brains, addressing normal and dysfunctional cell behavior. This award supports long-term research on regenerative properties of progenitor cells and their role in neurological diseases.
A new study from the University of Virginia identifies a compound that can recruit oligodendrocytes, a type of glial cell, to repair damage in the peripheral nervous system. This finding has implications for treating debilitating neurological disorders such as muscular dystrophy and Charcot-Marie-Tooth disease.
Researchers found that older cells in MS patients can reform myelin, but new oligodendrocyte generation is severely limited. This suggests treating MS aggressively at an early stage is crucial to prevent further damage.
A study published in Nature found that people with multiple sclerosis have different types of oligodendrocytes than healthy individuals, which may explain why their myelin repair process does not work as well. This discovery could lead to the development of new treatments for progressive MS.
Researchers at the University of Chicago Medical Center have found a promising treatment for multiple sclerosis, a disabling immune-mediated disease that damages nerve fibers. Sephin1, a small molecule, may delay harm to nerve cells by protecting oligodendrocytes and reducing inflammation.
A University at Buffalo team discovered that activation of PRRX1 induces pathological quiescence, rendering adult stem cells incapable of producing myelin-forming oligodendrocytes. This finding presents a novel approach to developing treatments for multiple sclerosis and other inflammatory diseases by blocking pathological quiescence.
Researchers have discovered significant abnormalities in nerve connections and myelin production in cells from patients with schizophrenia. These findings suggest a potential new model for studying psychotic disorders, which could lead to better treatment approaches.
Mature oligodendrocytes have been found to be capable of remyelinating damaged axons, suggesting a potential new target for treating multiple sclerosis. This discovery opens up new avenues for slowing or reversing the disease by promoting the activity of these cells.
Researchers at Karolinska Institutet discovered that oligodendrocytes, cells responsible for myelin production, may play a significant role in MS development. This finding could lead to new therapies targeting areas beyond the immune system.
Researchers at Case Western Reserve University developed a new method to generate brain stem cells, paving the way for greater understanding of myelin disease. The findings also provide new insights and therapeutic strategies for Pelizaeus-Merzbacher disease, a rare genetic disorder affecting male children.
Researchers at ASRC uncover the role of PRMT5 in myelin production, finding it essential for oligodendrocyte differentiation and cell survival. The study provides new insights into myelin formation mechanisms and potential therapeutic strategies for treating CNS diseases.
Bioengineering professor TK Kozai is developing in vivo imaging technology to investigate the role of oligodendrocytes and oligodendrocyte progenitor cells in chronic brain implant degradation. This research aims to identify targets for intervention strategies to improve device performance.
Researchers at Cincinnati Children's Hospital Medical Center have uncovered the biological role of the CHD8 gene in developing oligodendrocytes, cells that form a protective insulation around nerves. Modulating CHD8 activity may help restore neuronal connections and reduce symptoms in people with autism spectrum disorder.
A chemical compound called indazole chloride has been shown to produce beneficial inflammation and remyelination in multiple sclerosis patients. This process can help repair damaged axons and restore myelin, potentially reducing disability burden. The findings provide a promising new treatment avenue for the disease.
Researchers at UNICAMP developed a new method to increase the resolution of proteomic analysis by mass spectrometry, identifying 10,390 proteins expressed in oligodendrocytes. This improved resolution enables the study of previously undetectable proteins, potentially leading to novel therapeutic approaches for schizophrenia.
Researchers developed a neutralizing agent for CSPGs that inhibit oligodendrocyte migration and differentiation. Protamine was found to inhibit CSPG-mediated inhibition of oligodendrocyte differentiation, enhancing myelination in the developing mouse brain and remyelination in adult mice.
Researchers have developed a novel in vitro platform to analyze zebrafish oligodendrocyte progenitor cells, which could lead to improved spinal cord repair in humans. The system allows for efficient and controlled analysis of these cells, enabling the study of their differentiation into mature oligodendrocytes.
Researchers have found that interaction between mesenchymal and adult neural stem cells can strongly promote oligodendrogenesis, potentially leading to improved treatment options for Multiple Sclerosis. The study's results demonstrate conservation across species, offering hope for clinical translation.
A new study published in PLOS Biology reveals that different firing patterns of neurons alter proliferation and differentiation of oligodendrocyte precursors, which provide insulation to neuronal axons. The findings suggest a complex interplay between neurons and non-neuronal cells supporting them.
University at Buffalo researchers have developed a method to compare human and rodent cells, providing insight into gene expression patterns conserved across species. This approach identified a new gene involved in myelin repair that may become a therapeutic target for MS patients.
A team of researchers has identified a rare human mutation that causes a devastating neurological disease, similar to conditions affecting the production and maintenance of myelin in rats. The discovery provides a new model for understanding and treating these diseases.
Researchers at Boston Children's Hospital have identified a new cause of brain defects in tuberous sclerosis complex (TSC) patients. The study reveals that a protein called connective tissue growth factor (CTGF) impedes oligodendrocyte development and myelination in the brains of TSC patients.
Researchers found that glial cells experience bigger changes than neurons as people age, with astrocytes and oligodendrocytes shifting their regional gene expression patterns upon aging. The study provides a tool to understand how aging in the brain may be linked to the causes of age-related disorders.
Researchers identified a characteristic feature of oligodendrocyte myelination, which selectively targets axons from specific brain regions. This discovery may provide insights into neurological disorders like multiple sclerosis and suggest new avenues for understanding higher brain function.
Researchers at Karolinska Institutet identified 12 subclasses of oligodendrocytes and a novel cell distinct from oligodendrocytes residing in blood vessels, uncovering unexpected diversity within the nerve-insulating cells.
A study by Kyoto University reveals that a cancer suppression protein may contribute to ALS disease progression. The research found that the malfunctioning of nerve support cells and misfolding of protein TDP-43 play key roles in ALS development.
A new mouse model study suggests that the death of specific brain cells may trigger an autoimmune response against myelin, a characteristic of multiple sclerosis. Nanoparticle therapy has been shown to prevent this reaction, offering potential new treatments for humans.
Researchers identified a nuclear receptor protein called RXRgamma, which promotes OPC differentiation and remyelination. A vitamin D-activating drug may enhance remyelination in MS patients by controlling myelin sheath regeneration.
Researchers discovered that antiretroviral therapies can interfere with myelin production in the brain, leading to cognitive impairments. The study suggests a need for rethinking HIV drug design and prescription, particularly for children, to improve patient outcomes.
A new study aims to understand MS pathology by activating metabolic stress in oligodendrocytes, a type of cell that produces myelin. The research seeks to determine if this nonimmune-mediated animal model can recapitulate MS pathology and find evidence for behavioral changes and cognitive decline.
A study found that guanabenz, a blood pressure medication, enhances an innate cellular protective response and prevents myelin loss in animal models of multiple sclerosis. The drug's unique mechanism provides protection against MS by reducing inflammation and preserving myelin levels.
By disabling the Wnt signaling pathway, researchers may be able to repair damaged white matter in the brain, a potential breakthrough in treating cerebral palsy and multiple sclerosis. The study's findings suggest that targeting the Daam2/PIP5K interaction could accelerate oligodendrocyte differentiation and promote myelination.
Researchers identified a gene called Gpr56 that regulates nerve cell insulation in the central nervous system. Without proper insulation, nerve cells can't transmit signals efficiently, leading to diseases like multiple sclerosis.
Researchers at Karolinska Institutet discovered that human brains have a higher rate of oligodendrocyte maintenance and can modulate myelin production, enabling faster adaptation and learning. This finding has significant implications for understanding neurological diseases such as MS.
The study reveals that miRNA-9 negatively regulates oligodendrocyte lineage gene 1 during hypoxic-ischemic brain damage. This regulation is crucial for understanding the molecular mechanisms underlying brain damage and myelin repair.
Researchers at The New York Stem Cell Foundation have developed a new protocol to induce pluripotent stem cells into oligodendrocytes, the myelin-forming cells implicated in multiple sclerosis. This accelerated approach cuts production time almost in half, enabling researchers to study disease progression and develop potential treatments.
Researchers at the University at Buffalo have identified SOX10 as a key transcription factor that initiates myelination in human brain cells. This discovery brings researchers closer to developing a viral or pharmaceutical approach to inducing SOX10 in MS patients, which could lead to a more effective treatment for multiple sclerosis.
Researchers found that miRNA-9 binds to and potentially reduces the activity of oligodendrocyte lineage gene 1 during hypoxic-ischemic brain injury. This regulatory mechanism may play a role in myelin repair and neurological disorder development.
A study found that co-culturing dorsal root ganglion neurons with type-2 astrocytes increases neuronal survival rates and process lengths. However, the effect is weaker compared to type-1 astrocytes and oligodendrocyte precursor cells.
An animal study shows that sleep increases the reproduction of oligodendrocytes, which form myelin in the brain and spinal cord, doubling their numbers during rapid eye movement sleep. This could lead to new insights into the role of sleep in brain repair and growth.
Researchers at Johannes Gutenberg University Mainz have discovered a new form of communication between brain cell types, where oligodendrocytes release exosomes with protective proteins and genetic information to neurons, protecting them against stress. This bidirectional communication plays a significant role in preserving nerve fibers.
Researchers discovered that individual oligodendrocytes can coat neurons with myelin for only five hours after birth. This finding could lead to new treatment strategies for multiple sclerosis, including targeting the blockages that prevent cells from producing myelin.
Neuroscientists at Johns Hopkins discovered that progenitor cells in the adult brain are highly dynamic, transforming into cells that insulate nerve fibers and help form scars. These cells communicate with each other to maintain a regular distribution throughout the brain and spinal cord.
Researchers at CWRU School of Medicine discover a technique to directly convert skin cells into myelinating brain cells, potentially treating multiple sclerosis and cerebral palsy. The new method enables rapid production of functional oligodendrocytes, which provide insulation for neurons.
A study published in Nature Neuroscience reveals that oligodendrocytes play a significant role in the early stage of ALS, with changes occurring long before physical symptoms appear. Suppressing an ALS-causing gene in oligodendrocytes delays disease onset and prolongs survival.
A study published in Nature Neuroscience reveals that social isolation can reduce myelin production in mice, affecting the formation of new oligodendrocytes and leading to behavioral changes. Reintroduction into a social group reverses these effects, suggesting environmental factors play a crucial role in maintaining healthy nerve cells.
Researchers at Max Planck Institute of Experimental Medicine discovered that glial cells pass on metabolites to neurons, enabling them to generate energy. The study found that oligodendrocytes can replenish energy in nerve fibers through glycolysis, reducing oxidative stress and cell damage.
Researchers at Caltech have developed a gene therapy that stimulates the production of new oligodendrocytes from stem cells, enabling the brain to replace damaged myelin sheaths in demyelinating diseases like MS. The therapy uses leukemia inhibitory factor (LIF) to promote remyelination and reduce inflammation.
Researchers successfully converted stem cells from umbilical cords into oligodendrocytes, critical cells that insulate nerves in the brain and spinal cord. The breakthrough offers new hope for treating spinal cord injuries and multiple sclerosis by injecting healthy oligodendrocytes into the body.
A new study links an inherited mutation in the myelin oligodendrocyte gene (MOG) to rare forms of narcolepsy and multiple neuropsychiatric disorders. The research identifies a unique mutation present only in affected family members, highlighting the role of MOG in disease susceptibility.
Researchers at Johns Hopkins discovered that NG2+ cells undergo dramatic changes in ALS, growing rapidly and forming abnormal oligodendrocytes that quickly die. This overgrowth suggests a new player in the disease's progression.
Scientists have identified a molecular master switch that catalyzes the transition of precursor cells to mature oligodendrocytes in the brain. The molecule miR-219 plays a crucial role in this process, which has implications for treating diseases such as multiple sclerosis and gliomas.
A novel mouse model of demyelinating disorder has been developed, revealing the critical role of gene ZFP191 in CNS myelination. The study found that mice with a mutation in ZFP191 exhibit severe deficiency in CNS myelination, leading to tremors and seizures.
Case Western Reserve University researchers are using pluripotent stem cells to study schizophrenia and gain a better understanding of the complex disease. The study aims to characterize brain cell function in adolescent patients with schizophrenia, with the goal of deciphering the underlying cause of the condition.
Researchers from the University of Wisconsin successfully generated human embryonic stem cells that can produce myelin, a finding with potential for both basic and clinical research. The process takes 14 weeks compared to 2 weeks for mouse ES cells.
A new study found that variations of the OLIG2 gene are strongly associated with schizophrenia. The gene plays a crucial role in myelin production and is coordinated with other genes involved in myelination and schizophrenia development. This causal link may help researchers develop new therapeutic targets for the debilitating illness.
Researchers at UT Southwestern Medical Center are exploring the potential of reparative cells to repair damage in multiple sclerosis. The study identifies specific injury cascades and molecular mechanisms that could be targeted for treatment, offering a new avenue for fighting this debilitating disease.
Researchers at the University of Leicester have made a breakthrough in understanding the cause of brain damage and its link to various neurological diseases. The study identified glutamate receptors as the culprit behind oligodendrocyte damage, paving the way for potential treatments to block these receptors and prevent injury.
Researchers successfully remyelinated nearly entire mouse brains with human stem cells, producing thousands of times more myelin than previous experiments. This breakthrough offers potential treatment for diseases like Canavan disease and Tay-Sachs disease.
Researchers at the MNI have made a groundbreaking discovery about netrins, proteins that guide nerve cell axons to their target in the developing nervous system. The study suggests that netrin acts as a repellent cue for migrating oligodendrocytes, which could lead to new therapies for Multiple Sclerosis.